$CAPR I asked AJ last week in a phone conversation, what’s been driving the growth we’ve seen over the last couple of months? Seems like a dozen people at least. He replied, “Exosomes”. Not just for delivery of CAPR’s COVID vaccines and 1002, but anybody else’s vaccines/drugs. Relationships with Johns Hopkins and Cedars Sinai are key, we have world class scientists on our team making Capricor a go to firm for companies like MRNA, INO, PFE; anyone that wants to enhance efficacy through exosome delivery. Extremely bullish.